http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S61218520-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e45efeaa6a34dfd9d44fa29a7fe0c806 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D499-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D499-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-43 |
| filingDate | 1985-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f17c8c9253b1dd9be283bceeb3de79ce |
| publicationDate | 1986-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-S61218520-A |
| titleOfInvention | Remedy for infectious disease |
| abstract | PURPOSE: A remedy for infectious diseases having a bacterium resistant to ampicillin as a prophlogistic bacterium, comprising 6#-bromopenicillanic acid, its ester or ester and ampicillin, its salt or ester as active ingredients. n CONSTITUTION: A remedy for infectious diseases comprising a compound shown by the formula I, its salt (e.g., Na salt, K salt, etc.), or its ester (e.g., methoxymethyl, etc.), and a compound shown by the formula II, its salt (e.g., Na salt, K salt, etc.) or ester (e.g., methoxymethyl, etc.) in a ratio of the former to the latter of 100:1W1:100, preferably 2:1W1:2 and, if necessary, an auxiliary, stabilizer, etc. Tablet, granule, capsule, suppository, injection, emulsion, etc., may be cited as the dosage form. A dose is 100W5,000mg/day, or a larger dose can be administered. n EFFECT: Use of both the substances shows improved antibacterial action on bacteria resistant to ampicillin. n COPYRIGHT: (C)1986,JPO&Japio |
| priorityDate | 1985-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.